摘要 Intravesical prostatic protrusion (IPP) has emerged as a new prostatic morphometric parameter of significance to aid the clinicians in various aspects of managing the patients with some diseases of the lower urinary tract and the prostate. These include but may not be limited to its role in such conditions as:bladder outlet obstruction, trial without catheter, medical treatment effect, progression of lower urinary tract symptoms related to benign prostatic hypertrophy (LUTS/BPH), risk factor for bladder stone in BPH, overactive bladder, prostate carcinoma, and early urinary continence recovery after laparoscopic radical prostatectomy. In this review, I will try to summarize the different researchers' efforts on the potential practical application of this clinical tool. Technology is ever evolving to help us in the diagnosis and management of our patients. However, we as clinicians should contemplate their cost and possible suffering for the patient by wise and judicious utilization based on our clinical experience and tools. IPP seems to be one such promising clinical tool.
Abstract: Intravesical prostatic protrusion (IPP) has emerged as a new prostatic morphometric parameter of significance to aid the clinicians in various aspects of managing the patients with some diseases of the lower urinary tract and the prostate. These include but may not be limited to its role in such conditions as:bladder outlet obstruction, trial without catheter, medical treatment effect, progression of lower urinary tract symptoms related to benign prostatic hypertrophy (LUTS/BPH), risk factor for bladder stone in BPH, overactive bladder, prostate carcinoma, and early urinary continence recovery after laparoscopic radical prostatectomy. In this review, I will try to summarize the different researchers' efforts on the potential practical application of this clinical tool. Technology is ever evolving to help us in the diagnosis and management of our patients. However, we as clinicians should contemplate their cost and possible suffering for the patient by wise and judicious utilization based on our clinical experience and tools. IPP seems to be one such promising clinical tool.
作者简介: Darab Mehraban,E-mail address:darabm@gmail.com.
引用本文:
Darab Mehraban. Clinical value of intravesical prostatic protrusion in the evaluation and management of prostatic and other lower urinary tract diseases[J]. Asian Journal of Urology, 2017, 4(3): 174-180.
Darab Mehraban. Clinical value of intravesical prostatic protrusion in the evaluation and management of prostatic and other lower urinary tract diseases. Asian Journal of Urology, 2017, 4(3): 174-180.
[1] Guyon JCF. Clinical lectures on surgical disorders of bladder and prostate. Paris:J. B. Bailliére; 1888. [2] Ohnishi K, Watanabe H, Ohe H, Saitoh M. Development and clinical significance of protrusion of hypertrophic prostate into the bladder observed by transrectal ultrasonotomography. Nihon Hinyokika Gakkai Zasshi 1985;76:1194-200[Article in Japanese]. [3] Watanabe H. New concept of BPH:PCAR theory. Prostate 1998;37:116-25. [4] Yuen JSP, Ngiap JTK, Cheng CWS, Foo KT. Effects of bladder volume on transabdominal ultrasound measurements of intravesical prostatic protrusion and volume. Int J Urol 2002; 9:225-9. [5] Chia SJ, Heng CT, Chan SP, Foo KT. Correlation of intravesical prostatic protrusion with bladder outlet obstruction. BJU Int 2003;91:371-4. [6] Kuo TL, Teo JS, Foo KT. The role of intravesical prostatic protrusion (IPP) in the evaluation and treatment of bladder outlet obstruction (BOO). Neurourol Urodyn 2016;35:535-7. [7] Nose H, Foo KT, Lim KB, Yokoyama T, Ozawa H, Kumon H. Accuracy of two noninvasive methods of diagnosing bladder outlet obstruction using ultrasonography:intravesical prostatic protrusion and velocity-flow video urodynamics. Urology 2005;65:493-7. [8] Lim KB, Ho H, Foo KT, Wong MY, Fook-Chong S. Comparison of intravesical prostatic protrusion, prostate volume and serum prostatic-specific antigen in the evaluation of bladder outlet obstruction. Int J Urol 2006;13:1509-13. [9] Wang D, Huang H, Law YM, Foo KT. Relationships between prostatic volume and intravesical prostatic protrusion on transabdominal ultrasound and benign prostatic obstruction in patients with lower urinary tract symptoms. Ann Acad Med Singap 2015;44:60-5. [10] Tan YH, Foo KT. Intravesical prostatic protrusion predicts the outcome of a trial without catheter following acute urine retention. J Urol 2003;170(6 Pt 1):2339-41. [11] Mariappan P, Brown DJ, McNeill A. Intravesical prostatic protrusion is better than prostate volume in predicting the outcome of trial without catheter in white men presenting with acute urinary retention:a prospective clinical study. J Urol 2007;178:573-7. [12] Tiong HY, Tibung MJ, Macalalag M, Li MK, Consigliere D. Alfuzosin 10 mg once daily increases the chances of successful trial without catheter after acute urinary retention secondary to benign prostate hyperplasia. Urol Int 2009;83:44-8. [13] Bhomi KK, Bhattachan CL. Factors predicting the success of a trial without catheter in acute urinary retention secondary to benign prostatic hyperplasia. Nepal Med Coll J 2011;13:178-81. [14] Syazarina Sharis O, Zulkifli MZ, Hamzaini AH. Predicting outcome of trial of voiding without catheter in acute urinary retention with intravesical prostatic protrusion. Malays J Med Sci 2013;20:56-9. [15] Park HY, Lee JY, Park SY, Lee SW, Kim YT, Choi HY, et al. Efficacy of alpha blocker treatment according to the degree of intravesical prostatic protrusion detected by transrectal ultrasonography in patients with benign prostatic hyperplasia. Korean J Urol 2012;53:92-7. [16] Cumpanas AA, Botoca M, Minciu R, Bucuras V. Intravesical prostatic protrusion can be a predicting factor for the treatment outcome in patients with lower urinary tract symptoms due to benign prostatic obstruction treated with tamsulosin. Urology 2013;81:859-63. [17] Doo CK, Uh HS. Anatomic configuration of prostate obtained by noninvasive ultrasonography can predict clinical voiding parameters for determining BOO in men with LUTS. Urology 2009;73:232-6. [18] Kalkanli A, Tandogdu Z, Aydin M, Karaca AS, Hazar AI, Balci MB, et al. Intravesical prostatic protrusion:a potential marker of alpha-blocker treatment success in patients with benign prostatic enlargement. Urology 2016;88:161-5. [19] Lee JW, Ryu JH, Yoo TK, Byun SS, Jeong YJ, Jung TY. Relationship between intravesical prostatic protrusion and postoperative outcomes in patients with benign prostatic hyperplasia. Korean J Urol 2012;53:478-82. [20] Kim MS, Park KK, Chung BH, Lee SH. Effect of photoselective vaporisation prostatectomy on lower urinary tract symptoms in benign prostatic hyperplasia with or without intravesical prostatic protrusion. Korean J Urol 2013;54:S36-41. [21] Kang SH, Choi YS, Kim SJ, Cho HJ, Hong SH, Lee JY, et al. Long-term follow-up results of photoselective vaporization of the prostate with the 120 W greenlight HPS laser for treatment of benign prostatic hyperplasia. Korean J Urol 2011;52:260-4. [22] Hirayama K, Masui K, Hamada A, Shichiri Y, Masuzawa N, Hamada S. Evaluation of intravesical prostatic protrusion as a predictor of dutasteride-resistant lower urinary tract symptoms/benign prostatic enlargement with a high likelihood of surgical intervention. Urology 2015;86:565-9. [23] Lee LS, Sim HG, Lim KB, Wang D, Foo KT. Intravesical prostatic protrusion predicts clinical progression of benign prostatic enlargement in patients receiving medical treatment. Int J Urol 2010;17:69-74. [24] Kim JW, Oh MM, Park HS, Cheon J, Lee JG, Kim JJ, et al. Intravesical prostatic protrusion is a risk factor for bladder stone in patients with benign prostatic hyperplasia. Urology 2014;84:1026-9. [25] Tong YC, Lin YM, Yang WH, Tzai TS, Lin JS. Correlation of transrectal ultrasonographic findings of the prostate with the occurrence of detrusor instability in patients with benign prostatic hyperplasia. Urol Int 1995;55:154-7. [26] Lee JM, Chung H, Kim TW, Kim HS, Wang JH, Yang SK. The correlation of intravesical prostatic protrusion with storage symptoms, as measured by transrectal ultrasound. Korean J Urol 2008;49:145-9. [27] Kim KH, Kim YS. Correlation of male overactive bladder with intravesical prostatic protrusion. Korean J Urol 2010;51:843-6. [28] Xu D, Yu Y, Zhu Y, Huang T, Chen Y, Qi J. A new model consists of intravesical prostatic protrusion, prostate polume and serum prostatic-specific antigen in the evaluation of prostate cancer. Pathol Oncol Res 2014;20:439-43. [29] Lee CH, Ha HK. Intravesical prostatic protrusion as a predictor of early urinary continence recovery after laparoscopic radical prostatectomy. Int J Urol 2014;21:653-6. [30] Maeda Y. Editorial comment to intravesical prostatic protrusion as a predictor of early urinary continence recovery after laparoscopic radical prostatectomy. Int J Urol 2014;21:657. http://dx.doi.org/10.1111/iju.12443. [31] Bantis A, Zissimopoulos A, Kalaytzis C, Giannakopoulos S, Sountoulides P, Agelonidou E, et al. Correlation of serum prostate specific antigen, the volume and the intravesical prostatic protrusion for diagnosing bladder outlet obstruction in patients with benign prostate hyperplasia. Hell J Nucl Med 2007;10:138-43. [32] Sakuyama G, Ishii T, Yamanishi T, Igarashi T. Hydrodynamic aspects of intravesical protrusion of the prostate in patients with voiding dysfunction. Urol Suppl 2011;78:3. [33] Zheng J, Pan J, Qin Y, Huang J, Luo Y, Gao X, et al. Role for intravesical prostatic protrusion in lower urinary tract symptom:a fluid structural interaction analysis study. BMC Urol 2015;19:86.
Christopher Hartman, Nikhil Gupta, David Leavitt, David Hoenig, Zeph Okeke, Arthur Smith. Advances in percutaneous stone surgery[J]. Asian Journal of Urology, 2015, 2(1): 26
-32
.
